A supplemental appendix to this article is published electronically only at http://jdr.sagepub.com/supplemental.
InTRODuCTIOn
B one marrow mesenchymal stem cells have been identified as a population of hierarchical post-natal stem cells with the potential to differentiate into various cell types such as osteoblasts, chondrocytes, and adipocytes (Friedenstein et al., 1974; Owen and Friedenstein, 1988; Beresford, 1989; Prockop, 1997; Azizi et al., 1998; Pittenger et al., 1999; Prockop et al., 2000; Toma et al., 2002; Gronthos et al., 2003) . Since orofacial skeletal components such as tooth and jaw bones have been considered to be developed from migrating cranial neural crest cells (Chai et al., 2000) , it is important to examine whether mouse orofacial bone/bone-marrow-derived MSCs (OMSCs) possess unique stem cell properties.
Human orofacial bone-marrow-derived MSCs have been shown to have characteristics distinct from those of human long-bone-marrow-derived MSCs (BMMSCs) in terms of differentiation traits (Matsubara et al., 2005; Akintoye et al., 2006) , but the interplay of human orofacial bone-marrowderived MSCs with immune cells, as seen in human BMMSCs, has not been explored. Mouse orofacial bone-marrow-derived MSCs have not yet been isolated, in part due to the small size and anatomically complicated structure of mouse jaw bones. In this study, we have developed a protocol to successfully isolate and expand mouse OMSCs. Also, we found that mouse OMSCs are distinct from mouse BMMSCs with respect to their interplay with T-cells.
MATERIAlS & METHODS

Mice
Female C3H-strain (7-to 8 week-old) and C57BL/6-Tg(CAG-EGFP) mice were purchased from the Jackson Laboratory (Bar Harbor, ME, USA). Immunocompromised beige nu/nu xid mice (8-to 10-week-old) were purchased from Harlan (Indianapolis, IN, USA). Ovariectomized C3H mice were analyzed at 4 wks post-surgery, and age-matched C3H mice were used as controls. Animal experiments in this study were performed under a research protocol approved by the Institutional Animal Care and Use Committee (University of Southern California, protocol #10874). All animals were maintained in a temperature-controlled room with a 12-hour alternating light-dark cycle and were fed sufficient diet and water ad libitum throughout the experimental period.
Antibodies
All primary antibodies used in this study are described in the Appendix.
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Isolation of Mesenchymal Stem Cells (MSCs) from Mouse Jaw (mandibular) and long Bones
We collected mandibular and long bones to isolate cells independently. The attached soft tissues and teeth, including incisors and molars, were removed from the bones. All nucleated cells (ANCs) from mandibular bones were obtained by digestion with 3 mg/mL collagenase type I (Worthington Biochem, Lakewood, NJ, USA) and 4 mg/mL dispase II (Roche Diagnostic, Indianapolis, IN, USA) for 60 min at 37°C. ANCs from long bones were obtained by flushing out from the bone marrow (Yamaza et al., 2008) . Single-cell suspensions of ANCs from mandibular or long bones were obtained through 70-μm cell strainers (BD Bioscience, San Jose, CA, USA), and seeded at 1 to 1.5 x 10 6 or 10 to 15 x 10 6 on a 100-mm dish (Corning, Corning, NY, USA), respectively. MSCs were isolated and cultured following an established protocol (Yamaza et al., 2008) . The cells formed single colonies, recognized as passage 0 (P0) MSCs, which were later collected and passed to P1 expansion for subsequent experiments. No feeder cells were used in MSC culture. Multiple colony MSCs derived from several mice (n = 3~5) were pooled and used in this study. Each test was repeated at least 3 times. To avoid hematopoietic cell contamination, we selected multiple numbers of single colony clusters and passed them to secondary culture.
Colony-forming units-Fibroblastic (CFu-F) Assay
Independent isolated ANCs were seeded and cultured for CFU-F assay as described previously (Yamaza et al., 2008) and in the Appendix.
Population-doubling (PD) Assay
Independent isolated MSCs were used in this assay. The detailed methods are described in the Appendix.
Cell Proliferation Assay
P1 MSCs were assayed for bromodeoxyuridine (BrdU) incorporation as described in the Appendix.
Immunophenotype Analysis
P1 MSCs were stained for cell-surface markers and analyzed by flow cytometry (see Appendix). Positive cells were identified by comparison with the corresponding control cells in which a false-positive rate of less than 1% was accepted.
Multi-lineage Differentiation Assay
MSCs (P1) were cultured under in vitro osteogenic, adipogenic, and chondrogenic conditions as described in the Appendix.
MSC-mediated Tissue Regeneration in vivo
P1 BMMSCs or OMSCs (2 x 10 6 cells each), mixed with hydroxyapatite/tricalcium phosphate (HA/TCP) ceramic powder (Zimmer, Warsaw, IN, USA), were implanted subcutaneously into immunocompromised mice, and analyzed as described in the Appendix.
Immunoblot Analysis
Immunoblotting was performed as described in the Appendix.
Isolation and Culture of Splenocytes and PanT-lymphocytes
Splenocytes and PanT cells were isolated and cultured (Appendix). The culture supernatant of PanT cells was enriched 10 times to use for conditioned media (CM).
Survival Assay for MSCs with Co-cultured PanT Cells P1 MSCs were co-cultured with activated or naïve PanT cells under several conditions, and assayed by toluidine blue staining or apoptotic staining (see Appendix).
Cell Proliferation and Cell Death Assay of Splenocytes Co-cultured with MSCs
Splenocytes were co-cultured with P1 MSCs by means of the ChemoTx Chemotaxis System (NeuroProbe, Gaithersburg, MD, USA) (see details in the Appendix). Cell proliferation of activated splenocytes was analyzed by 3 H-thymidine incorporation assay. DNA content in the cells was measured for cell death by flow cytometry.
Statistical Analysis
Each assay was repeated with 3 or 5 independent isolated cells and the results were averaged. Student's t test was used to analyze significance between two groups. A P value of less than 0.05 was considered as a significant difference.
RESulTS
Isolation and Characterization of Mouse OMSCs
Murine jaw bones contain a unique and complicated bone-bone marrow-tooth system (Appendix Fig. 1 ). To isolate OMSCs from mouse mandibles, we generated single-cell suspensions by enzyme digestion and plated them at a low density on plastic plates. OMSCs were capable of forming adherent clonogenic cell colonies originating from a single attached cell showing a typical fibroblast-like morphology (data not shown). These single colony clusters, termed colony-forming units-fibroblastic (CFU-F), were similar to primary cultured BMMSCs. However, OMSCs generated significantly higher numbers of CFU-F (55.33 ± 9.07 colonies per 1.5 x 10 6 cells/plate) than did BMMSCs (5.33 ± 0.58 per 1.5 x 10 6 cells/plate; P < 0.005) ( Fig.  1A ). In addition, OMSCs had a high number of population doublings and an elevated cell proliferation rate when compared with those of BMMSCs ( Fig. 1B) .
Next, we performed flow cytometric analysis to examine the surface molecular expression in OMSCs (Figs. 1E, 1F). OMSCs failed to express hematopoietic markers (CD14, CD34, and CD45), but were positive for MSC-associated markers (CD73, CD105, CD106, SSEA-4, and Oct-4). It appears that OMSCs expressed significantly higher levels of SSEA-4 and Oct-4 when compared with BMMSCs. OMSCs were also highly positive for stem cell antigen 1 (Sca-1) and weakly positive for c-kit. Interestingly, OMSCs expressed the embryonic stem cell markers, stage-specific embryonic antigen 4 (SSEA-4) and Octamer 4 (Oct-4), two early stem cell markers previously found to be present in embryonic stem cells and BMMSCs (Izadpanah et al., 2006; Lamoury et al., 2006; Gang et al., 2007) . The levels of expression of SSEA-4 (6.4%) and Oct-4 (6.0%) in OMSCs were higher than in BMMSCs (SSEA4, 4.2%; Oct-4, 2.6%), suggesting that OMSCs may contain a more primitive MSC subpopulation than BMMSCs.
Multi-lineage Differentiation of OMSCs
Under osteogenic culture conditions, OMSCs differentiated into osteoblasts and showed higher levels of alkaline phosphatase (ALP) activity ( Fig. 2A) , elevated capability of forming mineralized nodules (Fig. 2B) , and higher levels of expression of osteoblastic markers, Runx2, ALP, and osteocalcin (OCN; Fig. 2C ) when compared with BMMSCs. Moreover, OMSCs had a capacity to differentiate into Oil-red O-positive lipid-laden adipocytes and expressed adipogenic markers, lipoprotein lipase (LPL) and peroxisome proliferator-activated receptor γ2 (PPARγ2). The adipogenic differentiation capacity of OMSCs was similar to that of BMMSCs (Figs. 2D, 2E). Alcian blue staining showed that OMSCs were capable of forming cartilage matrix in chondrogenic inductive aggregated cultures, as seen in BMMSCs (Figs. 2F, 2G). Also, safranin-O, toluidine blue, and anti-type II collagen antibody staining indicated that the capability of OMSCs to differentiate into chondrogenic cells is similar to that of BMMSCs (Appendix Fig. 2 ). When ex vivo-expanded OMSCs were transplanted into immunocompromised mice with hydroxyapatite/tricalcium phosphate (HA/TCP) as a carrier, OMSCs formed de novo bone structure on HA/TCP surfaces, as seen in BMMSC transplants (Fig. 2H ). Interestingly, OMSCs generated a larger amount of bone tissue and fewer bone marrow elements than BMMSCs (Figs. 2I, 2J). In GFP mousederived OMSC transplants, we found both GFP-positive osteocytes and GFP-negative osteocytes (Figs. 2K, 2L), suggesting that donor OMSCs and recipient cellular components may contribute to new bone formation. 
Interplay between OMSCs and T-lymphocytes
To examine whether T-lymphocytes affect OMSCs in vivo, we used ovariectomized (OVX) mice. Increased T-lymphocyte activation has been known to participate in bone loss in estrogendeficient model OVX mice (Cenci et al., 2000; Roggia et al., 2001) . It has been known that OVX caused a significant increase in the numbers of CFU-F in mouse BMMSCs, which may be a compensatory response to the reduced bone mineral density in OVX conditions (Miura et al., 2004) . Here we found that OMSCs derived from OVX mice (OVX-OMSCs) showed a significantly increased number of CFU-F compared with OMSCs from sham mice (sham-OMSCs) (Figs. 3A, 3B ). However, OVX-OMSCs showed similar cell proliferation rates (Figs. 3C, 3D ) and a tendency to decreased osteogenic capability (Figs. 3E, 3F ) compared with sham-OMSCs. RT-PCR and immunoblot analyses revealed that OVX-OMSCs showed partial deficiency of molecular expression in their osteogenic differentiation pathway (Appendix Figs. 3, 4) .
Our previous report indicated that activated T-cells induce apoptosis of BMMSCs through the Fas/FasL pathway (Yamaza et al., 2008) . To determine whether activated T-cells also directly impinge on OMSCs, we co-cultured OMSCs with PanTlymphocytes. Although naïve PanT cells were unable to induce OMSC death, PanT cells activated by anti-CD3 antibody caused OMSC death, but not completely (Fig. 4A) . When OMSCs were separated from PanT cells in a transwell co-cultured system, OMSCs failed to show cell death (Fig. 4A ), suggesting that direct cell-cell contact is required to induce OMSC death by activated T-lymphocytes. Conditioned medium collected from activated PanT cells did not cause significant cell death in OMSCs (Fig. 4B) , and neutralization with a cocktail of antitumor necrosis factor α (TNFα) and anti-interferon γ (IFNγ) antibodies failed to prevent OMSC apoptosis (Fig. 4B) , indicating that soluble factors released from activated T-lymphocytes did not contribute to OMSC death. Furthermore, treatment with anti-Fas ligand (FasL) antibody or brefeldin A blocked OMSC death (Fig. 4C) . In contrast, concanamycin A did not induce OMSC apoptosis (Fig. 4C) , indicating that the Fas/FasL pathway, but not the perforine/granzyme pathway, contributes to the apoptosis of OMSCs. Terminal deoxynucleotidyl transferase-mediated dUTP-biotin nick-end labeling (TUNEL) staining was used to confirm that OMSC death was due to apoptosis (Fig. 4D) . Interestingly, we found that activated T-cells induced a greater cell death in BMMSCs than in OMSCs (Fig. 4D) , which might be associated with the lower level of expression of Fas in OMSCs compared with that in BMMSCs, by immunoblot analysis (Figs. 4E, 4F ).
OMSCs Modulate Cell Survival and Cell Proliferation of T-lymphocytes
Our recent study indicated that the immunosuppressive property of BMMSCs was due to a high level of nitric oxide (NO) production induced by IFNγ via inducible nitric oxide synthase (iNOS; Ren et al., 2008) . To compare the immunosuppressive BMMSCs (Sham-BMMSCs), respectively. (C,D) BrdU incorporation assay revealed that OVX-BMMSCs showed higher proliferation rates than sham-BMMSCs. However, statistically, there was no significant difference between OVX-OMSC and the sham-OMSC group. OVX-OMSCs showed higher proliferation rates than OVX-BMMSCs. (E,F) After 6 wks of culture in osteogenic conditions, OVX-BMMSCs showed significantly decreased capacity of forming mineralized nodules when compared with sham-BMMSCs by Alizarin red staining. However, statistically, there was no significant difference between the OVX-OMSC and sham-OMSC groups. OVX-OMSCs showed higher mineralized nodule-forming capacity than OVX-BMMSCs. The results were representative of 5 independent experiments. *P ≤ 0.05, ***P ≤ 0.005. The graph bars show means ± SD.
capacity of OMSCs with that of BMMSCs, we co-cultured anti-CD3 antibody-activated splenocytes with different ratios of OMSCs and BMMSCs in the presence or absence of anti-IFNγ antibody or the iNOS inhibitor, 1400W. When the MSC-tosplenocyte ratio was 1:80, significant inhibition of T-cell proliferation was observed in the OMSC group, but not in the BMMSC group (Fig. 4G ), suggesting that OMSCs had a stronger immunosuppressive effect than BMMSCs. This may be associated with the fact that OMSCs produced more NO than BMMSCs when treated with IFNγ and TNFα (Appendix Fig. 5 ). However, the inhibition effect of OMSCs was only partially blocked by anti-IFNγ antibody and iNOS inhibitor, indicating that other factor(s) might contribute to NO-mediated immunosuppression in OMSCs. Our previous studies demonstrated that BMMSCs are effective in preventing apoptosis of splenocytes in the absence of T-cell activation signals (Ren et al., 2008) . Herein, when the MSC-to-splenocyte ratio was 1:20, 12% of naïve splenocytes underwent apoptosis in OMSCs cultures PanT culture-derived conditioned medium (CM) did not induce OMSC and BMMSC death. Neutralization with anti-IFNγ and anti-TNFα antibodies (1 μg/mL each) did not inhibit OMSC and BMMSC death. (C) Treatment with anti-FasL antibody (1 μg/mL) and brefeldin A (BFA, 10 mM), but not concanamycin A (ConA, 100 nM), blocked OMSC and BMMSC death. (D) The TUNEL-positive OMSC apoptosis rate was significantly less than the rate of BMMSC apoptosis. The percentage of TUNEL-positive (TUNEL+) nuclei was calculated compared with the total number of MSCs. (E) OMSCs expressed a significantly lower level of Fas compared with that in BMMSCs, by immunoblotting. (F) Cell proliferation of activated splenocytes was measured under BMMSC-or OMSC-co-culture system by 3 H-thymidine incorporation assay. OMSCs suppressed splenocyte proliferation more effectively than BMMSCs. Anti-IFNγ antibody (25 μg/mL) or 1400W (0.2 mM) treatment showed partial inhibition of splenocyte proliferation in the OMSC or BMMSC co-culture system. (G) Naïve splenocytes were co-cultured with OMSCs or BMMSCs at different ratios for 60 hrs, and stained with propidium iodide for measurement of DNA contents by flow cytometry. OMSCs were more effective in inhibiting spontaneous apoptosis of naïve splenocytes compared with BMMSCs. Numbers on the histograms show averaged percentiles of cells containing hypodiploid DNA contents. The results are representative of 5 (A-D) or 3 (E-G) independent experiments. *P ≤ 0.05, ***P ≤ 0.005. The graph bars or values show means ± SD. compared with 24% apoptotic naïve splenocytes in BMMSC culture (Fig. 4H ), suggesting that OMSCs were more effective in maintaining naïve splenocyte viability than BMMSCs.
DISCuSSIOn
Embryologic development and amalgamations of the complex array of bones and cartilage in the craniofacial region have revealed that the molecular mechanisms controlling skeletogenesis in the orofacial bones are unique and different from that in the axial and appendicular bones (Helms and Schneider, 2003) . The discrepancy in bone development between orofacial bones and long axial/appendicular bones give rises to specific diseases in the orofacial bone region, such as periodontitis, cherubism (Ueki et al., 2001) , and hyperparathyroid jaw tumor syndrome (Simonds et al., 2002) , which affect only the bones of the jaw. Therefore, it is not surprising to find that human OMSCs are distinct from BMMSCs in terms of differentiation traits (Matsubara et al., 2005; Akintoye et al., 2006) . In this study, we successfully isolated MSCs from mouse mandibular bones, OMSCs, and demonstrated their unique differentiation capacities and immunomodulatory properties, suggesting a potential use for a variety of mouse models to study dental and orofacial diseases.
Since mouse jaw bones contain limited quantities of marrow components, it is difficult to collect and expand MSC from the jaw bone marrow. Therefore, we used an enzyme digestion method to isolate MSCs from mandibular bones, and verified their MSC properties by clonogenic, multi-lineage differentiation, and tissue regeneration assays in comparison with mouse BMMSCs. It was reported that bone and bone marrow contain MSCs with similar stem cell properties, but slightly different in terms of surface molecule expression (Sanchez-Guijo et al., 2009) . It is likely that OMSCs contain post-migrating cranial neural crest cells (Chung et al., 2009 ). Analogous to BMMSCs, OMSCs are a mixed MSC population containing cells derived from mandibular bone and bone marrow.
Ex vivo-expanded BMMSCs are capable of suppressing T-lymphocyte activity in vitro, which provides a foundation for the use of BMMSC transplantation to treat T-cell-associated disorders, such as acute graft-vs.-host-disease (GvHD) in mice and humans (Koc et al., 2002; Bartholomew et al., 2002; Deng et al., 2004; Xu et al., 2007; Ren et al., 2008) . In contrast, activated T-lymphocytes can induce apoptosis of BMMSCs through the Fas/FasL pathway (Yamaza et al., 2008) . Analysis of our data suggests that OVX-induced T-lymphocyte activation may contribute to OMSC differentiation deficiency. However, we cannot exclude other factors that may also contribute to OMSC deficiency in OVX mice. In general, the immunomodulatory property of MSCs may be associated with a high level NO production induced by IFNγ via enhanced iNOS expression in BMMSCs (Ren et al., 2008) . In this study, we found that mouse OMSCs showed a stronger suppressive effect on the proliferation of anti-CD3 antibody-activated T-cells, along with high levels of NO production, when stimulated with IFNγ. We also found that OMSCs were capable of maintaining naïve splenocyte, including T-cell, survival more effectively than BMMSCs. Therefore, it is necessary to continue elucidating the underlying mechanisms of the interplay between OMSCs and immunity in various established mouse models.
Mouse OMSCs presented higher potency for osteoblastic differentiation than mouse BMMSCs, implying a site-specific boneregenerating capacity, as seen in human OMSCs (Matsubara et al., 2005; Akintoye et al., 2006) . Previously, SSEA-4 and Oct-4 were identified as embryonic stem cell markers, but recent studies have shown that human and rodent BMMSCs (Izadpanah et al., 2006; Lamoury et al., 2006; Gang et al., 2007) express SSEA-4 and Oct-4. It appears that these embryonic stem cell markers are expressed in early progenitors of BMMSCs. We found that OMSCs express significantly higher levels of SSEA-4 and Oct-4 than BMMSCs, suggesting that mouse OMSCs may contain more primitive stem cell progenitors.
